MSB was taking a Phase 3 Human Trial.... likely couldve been fast tracked or rushed too.
Rates of failure increase with every stage you go up.
IHL could only need either no human trial or a phase 1 human trial to get EUA from the FDA.
MSB is also a 2 billion dollar company.
IHL is 150M MC.
Massive risk/reward discrepancy here.
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-124
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online